EXETF Stock Chart & Stats
$22.07
$0.00(0.00%)
At close: 4:00 PM EDT
$22.07
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$10.53 - $28.45
Previous CloseN/A
Volume70.00
Average Volume (3M)34.10K
Market Cap
$1.78B
Enterprise Value$3.94B
Total Cash (Recent Filing)$93.47M
Total Debt (Recent Filing)$645.75M
Price to Earnings (P/E)20.2
Beta0.08
Next Earnings
Nov 05, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend Yield1.92%
Share Statistics
EPS (TTM)1.32
Shares Outstanding95,046,400
10 Day Avg. Volume68,564
30 Day Avg. Volume34,102
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)4.88
Price to Sales (P/S)1.10
P/FCF Ratio28.76
Enterprise Value/Market Cap2.21
Enterprise Value/Revenue1.99
Enterprise Value/Gross Profit5.04
Enterprise Value/Ebitda18.46
Forecast
1Y Price Target
$27.33Price Target Upside23.84% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.06
Revenue Forecast (FY)$1.62B
Bulls Say, Bears Say
Bulls Say
Scalable Growth Through Acquisitions And Organic DemandRapid revenue and EBITDA growth, combined with strong organic home-health volume gains outside CBI, indicates Extendicare is expanding beyond acquisition effects. This broader growth base can improve operating scale, support reinvestment, and strengthen the company’s position in a growing seniors-care market over coming quarters.
Improved Liquidity And Debt Maturity ProfileThe unsecured financing and additional liquidity improve financial flexibility while extending maturities and lowering the average interest rate. A more resilient capital structure gives Extendicare greater capacity to fund redevelopment, absorb integration spending, and manage operating volatility without relying as heavily on near-term refinancing.
Redevelopment Pipeline Supports Long-term Capacity GrowthThe redevelopment pipeline provides a visible path to expanding and modernizing long-term-care capacity. New beds and upgraded homes can improve service capability, support future occupancy and funding opportunities, and create a durable growth platform beyond the current acquisition cycle.
Bears Say
Elevated Leverage And Inconsistent Cash ConversionLeverage has improved from earlier highs but has recently risen, leaving the capital structure sensitive to execution or operating setbacks. Weak conversion of earnings into free cash flow further limits internally funded investment capacity and could constrain flexibility while the company integrates acquisitions and develops new homes.
Home-health Margin Pressure And Uncertain Rate TimingHome-health growth is currently requiring technology and back-office investment, while the absence of a 2026 Ontario rate increase pressures margins. If funding adjustments remain delayed, cost growth may outpace reimbursement for longer, limiting the profitability contribution from the company’s fastest-growing service area.
Integration Costs And Execution Remain MaterialThe acquisition strategy creates a substantial integration workload across systems, regions, and transitional services. Costs incurred before synergies are fully realized can weigh on near-term earnings and cash flow, while execution delays could postpone the expected benefits and increase management complexity during a period of rapid expansion.
Extendicare News
EXETF FAQ
What was Extendicare’s price range in the past 12 months?
Extendicare lowest stock price was $10.53 and its highest was $28.45 in the past 12 months.
What is Extendicare’s market cap?
Extendicare’s market cap is $1.78B.
When is Extendicare’s upcoming earnings report date?
Extendicare’s upcoming earnings report date is Nov 05, 2026 which is in 21 days.
How were Extendicare’s earnings last quarter?
Extendicare released its earnings results on Aug 06, 2026. The company reported $0.225 earnings per share for the quarter, missing the consensus estimate of $0.278 by -$0.054.
Is Extendicare overvalued?
According to Wall Street analysts Extendicare’s price is currently Undervalued.
Does Extendicare pay dividends?
Extendicare pays a Monthly dividend of $0.031 which represents an annual dividend yield of 1.92%. See more information on Extendicare dividends here
What is Extendicare’s EPS estimate?
Extendicare’s EPS estimate is 0.25.
How many shares outstanding does Extendicare have?
Extendicare has 95,046,400 shares outstanding.
What happened to Extendicare’s price movement after its last earnings report?
Extendicare reported an EPS of $0.225 in its last earnings report, missing expectations of $0.278. Following the earnings report the stock price went down -5.684%.
Which hedge fund is a major shareholder of Extendicare?
Currently, no hedge funds are holding shares in EXETF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Extendicare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.33 (23.84% Upside)
$27.33 (23.84% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.7%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
86.23%
12-Months-Change
Fundamentals
Return on Equity
36.33%
Trailing 12-Months
Asset Growth
100.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Extendicare
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care facilities, a range of retirement living options, and comprehensive home-based health services. These home health offerings span professional nursing care, various rehabilitative therapies (including occupational, physical, and speech therapy), and assistance with everyday activities. Additionally, Extendicare offers contract and consulting expertise to external entities. The organization oversees an extensive network consisting of 119 long-term care residences and retirement communities, alongside its dedicated home health care operations. These services are provided under prominent brand names such as Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network. Founded in 1968, Extendicare Inc. is headquartered in Markham, Canada.
EXETF Stock 12 Month Forecast
Average Price Target
$27.33
▲(23.84% Upside)
Technical Analysis
Ownership Overview
8.04% Insiders
1.27% Mutual Funds
0.09% Other Institutional Investors
84.26% Public Companies and
Individual Investors